Therapy Areas: Infectious Diseases
19 July 2019 - - US-based biopharmaceutical company Cortexyme, Inc. (NASDAQ: CRTX) has presented clinical data that supports its ongoing work to pioneer a novel, disease-modifying therapeutic approach...
19 July 2019 - The US Food and Drug Administration (FDA) has granted approval to United States-based Merck for its Recarbrio (imipenem, cilastatin and relebactam) intended to treat adults with complic...
18 July 2019 - - The US Food and Drug Administration has approved Recarbrio (imipenem, cilastatin, and relebactam) for injection, 1.25 grams, a new combination antibacterial, US-based pharmaceutical c...
18 July 2019 - The US Food and Drug Administration (FDA) on Wednesday cleared the marketing of the antibacterial drug Recarbrio (imipenem, cilastatin and relebactam), for adults with complicated urina...
16 July 2019 - - The US Food and Drug Administration has granted a Breakthrough Therapy Designation to DCR-PHXC for the treatment of patients with primary hyperoxaluria type 1, US-based ribonucleic ac...
16 July 2019 - - US-based biopharmaceutical company Recursion has closed a USD 121m Series C financing, the company said.
The round was led by Baillie Gifford's flagship investment trust, S...
Related Headlines